News

Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...
Novo Nordisk has implemented a global hiring freeze covering job roles that are not critical for its business, Reuters writes ...
Novo Nordisk surges as Wegovy secures FDA approval for MASH, marking a breakthrough in liver care and expanding its blockbuster reach.
Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those with previous adverse reactions.
GoodRx is joining the GLP-1 action with an announcement Monday to begin selling both Novo Nordisk's GLP-1 drugs, Ozempic and Wegovy, at a cash price of $499 per month.
The company hopes an important CVS deal and broader legal action against the makers of knockoff Wegovy can solidify its ...
Tools like Claimable and Fight Health Insurance use AI to guide people through the insurance appeals process and generate ...
Longer-term studies will be needed to track whether per-patient costs might drop over time with continued use of the meds.
People enrolled in the military health care benefits program Tricare for Life no longer will be eligible for coverage of ...
GoodRx (GDRX) is joining in on the GLP-1 action with an announcement on Monday that it will begin selling both of Novo Nordisk's (NVO) GLP-1 drugs, Ozempic for diabetes and Wegovy for weight loss, at ...
Novo Nordisk NVO faced a significant setback in July after sharply reducing its 2025 outlook for both sales and operating ...
Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.